Note: Some of the drugs listed below are used off-label to treat these specific conditions
[DOI] [Google Scholar] Sarkar S, Fekete C, Lgrdi G, Lechan RM
Wegovy znacznie zmniejszyo ryzyko powanych niepodanych zdarze sercowo-naczyniowych (zgonu z przyczyn sercowo-naczyniowych, zawau serca i udaru mzgu), ktre wystpiy u 6,5 procent uczestnikw, ktrzy otrzymali Wegovy w porwnaniu z 8 procentami uczestnikw, ktrzy otrzymali placebo stwierdza FDA
To assess whether the anti-fibrotic activity of aloxistatin persists under pro-fibrotic conditions, HCFs were stimulated with TGF1, treated with aloxistatin and analyzed by mRNA sequencing (Fig
These cell lines were cultured in RPMI1640 medium (Gibco cat#11875119) supplemented with 5% Fetal Bovine Serum (BioWest, cat#S1620), 1% Penicillin/Streptomycin (Fischer Scientific, cat#15-140-122) and 1ug/ml Puromycin (Gibco, cat#A1113802)
[Google Scholar] Szabo S, Trier JS